<![CDATA[Hansa Biopharma — September 2021]]>Hansa Biopharma - Hansa Biopharma presented new data on imlifidase at the European Society for Organ Transplantation (ESOT) Congress.

https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2021/Hansa-Biopharma-presented-new-data-on-imlifidase-at-the-European-Society-for-Organ-Transplantation-ESOT-Congress/default.aspx

]]>https://dev.proinvestor.com/forum/topic/400718/hansa-biopharma-september-2021RSS for NodeSat, 06 Jun 2026 11:30:39 GMTWed, 01 Sep 2021 04:16:55 GMT60<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 30 Sep 2021 16:02:55 GMT]]>Temadag EPB. Søren Ulstrups afsluttende bemærkning i interview/spørgsmål: We have the opportunity to build the next Alexion or Shire. ( Alexion overtaget af Astrazeneca for 39B $, Shire overtaget af Takeda for 62B $).

]]>https://dev.proinvestor.com/forum/post/8005786https://dev.proinvestor.com/forum/post/8005786Thu, 30 Sep 2021 16:02:55 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 30 Sep 2021 05:25:36 GMT]]>09:15-09:55 Hansa Biopharma

]]>https://dev.proinvestor.com/forum/post/8005789https://dev.proinvestor.com/forum/post/8005789Thu, 30 Sep 2021 05:25:36 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 30 Sep 2021 05:24:34 GMT]]>Temadag Särläkemedel - Erik Penser Bank - 30 september 2021:

]]>https://dev.proinvestor.com/forum/post/8005790https://dev.proinvestor.com/forum/post/8005790Thu, 30 Sep 2021 05:24:34 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Mon, 27 Sep 2021 10:27:33 GMT]]>Hansa Biopharma short 2,56%.

]]>https://dev.proinvestor.com/forum/post/8005788https://dev.proinvestor.com/forum/post/8005788Mon, 27 Sep 2021 10:27:33 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Wed, 22 Sep 2021 12:33:50 GMT]]>🙂 🙂

]]>https://dev.proinvestor.com/forum/post/8005787https://dev.proinvestor.com/forum/post/8005787Wed, 22 Sep 2021 12:33:50 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Tue, 21 Sep 2021 18:40:45 GMT]]>Kurstriggere: 7- Ja så selvfølgelig den der bare ikke må ske, opkøb af hele butikken til emissionskurs Skr. 250 + 10-20%

]]>https://dev.proinvestor.com/forum/post/8005784https://dev.proinvestor.com/forum/post/8005784Tue, 21 Sep 2021 18:40:45 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Tue, 21 Sep 2021 18:32:48 GMT]]>Kurstriggere: 4- Ny genterapi-aftale. 5. Nye Reimbursaftaler. 6- Sektorrotation til biotek.

]]>https://dev.proinvestor.com/forum/post/8005785https://dev.proinvestor.com/forum/post/8005785Tue, 21 Sep 2021 18:32:48 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Tue, 21 Sep 2021 18:30:41 GMT]]>Kurstriggere: 1- Første nyretransplation usa-studie. 2- Samarbejde med Argenx går i klinikken med første projekt. 3- PM om opstart study to investigate DSA rebound in patients treated with imlifidase prior to transplation (levende organdonation).

]]>https://dev.proinvestor.com/forum/post/8005779https://dev.proinvestor.com/forum/post/8005779Tue, 21 Sep 2021 18:30:41 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Tue, 21 Sep 2021 18:22:50 GMT]]>Erik Penser Bank fortsætter køb i Hansa, i dag købt 52060 - solgt 0. Nu kunne det være rart med lidt nyheder, så vi kunne få sat de amerikanske banker under pres.

]]>https://dev.proinvestor.com/forum/post/8005777https://dev.proinvestor.com/forum/post/8005777Tue, 21 Sep 2021 18:22:50 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Wed, 15 Sep 2021 14:26:45 GMT]]>Link til MorganStanley webcast chat med CEO Søren Tulstrup og research analyst James Quigley, MorganStanley, UK https://morganstanley.webcasts.com/starthere.jsp?ei=1488480&tp_key=627eaeddc2

]]>https://dev.proinvestor.com/forum/post/8005783https://dev.proinvestor.com/forum/post/8005783Wed, 15 Sep 2021 14:26:45 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Wed, 15 Sep 2021 03:14:19 GMT]]>"Fireside chat" med CEO Sören Tulstrup and HCW analyst, Doug Tsao fra mandag d. September https://journey.ct.events/view/d8cfcd63-2a59-4466-92ad-5a4949c7c0e5

]]>https://dev.proinvestor.com/forum/post/8005781https://dev.proinvestor.com/forum/post/8005781Wed, 15 Sep 2021 03:14:19 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Tue, 14 Sep 2021 10:44:56 GMT]]>Hansa løfter sig en smule idag 🙂

]]>https://dev.proinvestor.com/forum/post/8005776https://dev.proinvestor.com/forum/post/8005776Tue, 14 Sep 2021 10:44:56 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Mon, 13 Sep 2021 04:23:10 GMT]]>Sep 13, 2021 HC Wainwright Healthcare Conference

Company collected consensus: Price Target, SEK 323 (Median).

H.C. Wainwright Presentation:

404 Not Found

favicon

(s24.q4cdn.com)

]]>https://dev.proinvestor.com/forum/post/8005775https://dev.proinvestor.com/forum/post/8005775Mon, 13 Sep 2021 04:23:10 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Fri, 10 Sep 2021 14:18:37 GMT]]>Dejligt at se at Erik Penser Bank (som analysedækker Hansa med et motiveret værdi på 350-360 Skr, og har en ikke risikojusteret værdi på 930 Skr pr. aktie) I dag er største nettokøber med købt 13.715 aktier og 0 solgte.

]]>https://dev.proinvestor.com/forum/post/8005774https://dev.proinvestor.com/forum/post/8005774Fri, 10 Sep 2021 14:18:37 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 09 Sep 2021 09:38:52 GMT]]>Redburn Gene Therapy Virtual Summit
September 7, 2021

404 Not Found

favicon

(s24.q4cdn.com)

]]>https://dev.proinvestor.com/forum/post/8005780https://dev.proinvestor.com/forum/post/8005780Thu, 09 Sep 2021 09:38:52 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 09 Sep 2021 05:23:59 GMT]]>TA på Tesla, Pandora, Ambu, Hansa Biopharma. https://www.proinvestor.com/boards/96815/TA-paa-4-spaendende-aktier-lidt-snak-om-gaeldsloft

]]>https://dev.proinvestor.com/forum/post/8005770https://dev.proinvestor.com/forum/post/8005770Thu, 09 Sep 2021 05:23:59 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Fri, 03 Sep 2021 09:50:55 GMT]]>og noget med op til 10 - 12% af alle transplantationer er i området med særlig sensitive. Ca. 20.000 pr år i EU --> potential ca. 2000 patienter bare EU

]]>https://dev.proinvestor.com/forum/post/8005772https://dev.proinvestor.com/forum/post/8005772Fri, 03 Sep 2021 09:50:55 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Fri, 03 Sep 2021 07:19:53 GMT]]>Iflg. Klaus Sindahl: "this is still not reimbursed yet". Men konklusionen er vel at det indrammer den kommende aftale, som jeg forstår det.

]]>https://dev.proinvestor.com/forum/post/8005773https://dev.proinvestor.com/forum/post/8005773Fri, 03 Sep 2021 07:19:53 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Fri, 03 Sep 2021 07:07:48 GMT]]>Med nuværende kurs giver det ca. DKK 3.168.000 - 6.336.000.

]]>https://dev.proinvestor.com/forum/post/8005778https://dev.proinvestor.com/forum/post/8005778Fri, 03 Sep 2021 07:07:48 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 02 Sep 2021 18:33:49 GMT]]>Beschluss
des Gemeinsamen Bundesausschusses über eine Änderung
der Arzneimittel-Richtlinie (AM-RL)
Anlage XII –Nutzenbewertung von Arzneimitteln mit neuen
Wirkstoffen nach § 35a SGB V:
Imlifidase (Desensibilisierung bei Nierentransplantation)

Imlifidase 426 020 – 852 040 €

https://www.g-ba.de/downloads/39-261-5002/2021-09-02_AM-RL-XII_Imlifidase_D-647.pdf

]]>https://dev.proinvestor.com/forum/post/8005782https://dev.proinvestor.com/forum/post/8005782Thu, 02 Sep 2021 18:33:49 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 02 Sep 2021 18:33:45 GMT]]>Blot link:

]]>https://dev.proinvestor.com/forum/post/8005767https://dev.proinvestor.com/forum/post/8005767Thu, 02 Sep 2021 18:33:45 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 02 Sep 2021 17:39:30 GMT]]>pump idag - dump imorgen..?

]]>https://dev.proinvestor.com/forum/post/8005768https://dev.proinvestor.com/forum/post/8005768Thu, 02 Sep 2021 17:39:30 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 02 Sep 2021 17:39:00 GMT]]>var det pump and dump idag...? Morgan Stanley handlede 100.000 stk med +20.000 i netto.

]]>https://dev.proinvestor.com/forum/post/8005771https://dev.proinvestor.com/forum/post/8005771Thu, 02 Sep 2021 17:39:00 GMT<![CDATA[Reply to Hansa Biopharma — September 2021 on Thu, 02 Sep 2021 16:04:49 GMT]]>Og husk, der er stadig frie hastighedsgrænser på de fleste autobahns i tyskland (-:

]]>https://dev.proinvestor.com/forum/post/8005766https://dev.proinvestor.com/forum/post/8005766Thu, 02 Sep 2021 16:04:49 GMT